Eli Lilly said its experimental pill met its goals in a pivotal study, helping diabetes patients lower blood sugar—and even reduce weight, bringing an oral version of the booming class of drugs ...

(Lilly is up about 16.5% over the last five trading ... Blenrep gets a second shot in the U.K. GSK’s multiple myeloma drug Blenrep has regained U.K. approval, now as part of a combination ...

Eli Lilly surged during Thursday's trading session after promising test results came out of the pharmaceutical company's ongoing weight-loss pill trial. Bernstein US biopharmaceuticals senior ...

INDIANAPOLIS, March 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be ...

The ninth Amanda K. Strous Memorial Field Hockey Scholarship has been awarded to Lilly Cantabene, a junior from York, ...